Treatment of Hepatitis C Virus-Associated Mixed Cryoglobulinemia with Sofosbuvir-Based Direct-Acting Antiviral Agents

BACKGROUND: Hepatitis C virus (HCV) is the most common cause of mixed cryoglobulinemia syndrome (MCS). The efficacy and safety of all-oral directly-acting antiviral (DAA) therapy in HCV-associated MCS (HCV-MCS) is largely unknown. METHODS: Case series of patients with HCV-MCS who were treated with s...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Hepatology
Main Authors: Sise, Meghan E., Bloom, Allyson K., Wisocky, Jessica, Lin, Ming V., Gustafson, Jenna L., Lundquist, Andrew L., Steele, David, Thiim, Michael, Williams, Winfred W., Hashemi, Nikroo, Kim, Arthur Y., Thadhani, Ravi, Chung, Raymond T.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4718772/
https://ncbi.nlm.nih.gov/pubmed/26474537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.28297
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki